Investors poured nearly $739 million into 40 women’s health funding rounds during the second quarter of 2026. FutureFemHealth’s Q2 2026 Women’s Health Funding Report says the average deal size was almost $20 million. Two companies, however, accounted for $222 million, or 30% of all funding, with FutureFemHealth Founder Anna O’Sullivan noting that “we inflate women’s health funding by including companies only partially exposed to the category, while simultaneously overlooking businesses where women’s health is hiding in plain sight.” FutureFemHealth, a media platform, recently created the FutureFemHealth Classification Framework to better drill down on the women’s health market.

Keep Reading

View More
arrow-right